Analyst Estimates: Here's What Brokers Think Of Corticeira Amorim, S.G.P.S., S.A. (ELI:COR) After Its First-Quarter Report

Investors in Corticeira Amorim, S.G.P.S., S.A. (ELI:COR) had a good week, as its shares rose 3.1% to close at €7.87 following the release of its quarterly results. Results overall were respectable, with statutory earnings of €0.52 per share roughly in line with what the analysts had forecast. Revenues of €229m came in 3.6% ahead of analyst predictions. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Corticeira Amorim S.G.P.S after the latest results.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Following last week's earnings report, Corticeira Amorim S.G.P.S' six analysts are forecasting 2025 revenues to be €934.5m, approximately in line with the last 12 months. Per-share earnings are expected to increase 9.7% to €0.58. Yet prior to the latest earnings, the analysts had been anticipated revenues of €938.6m and earnings per share (EPS) of €0.62 in 2025. So it looks like there's been a small decline in overall sentiment after the recent results - there's been no major change to revenue estimates, but the analysts did make a minor downgrade to their earnings per share forecasts.

View our latest analysis for Corticeira Amorim S.G.P.S

The consensus price target held steady at €10.73, with the analysts seemingly voting that their lower forecast earnings are not expected to lead to a lower stock price in the foreseeable future. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. The most optimistic Corticeira Amorim S.G.P.S analyst has a price target of €12.20 per share, while the most pessimistic values it at €8.84. As you can see, analysts are not all in agreement on the stock's future, but the range of estimates is still reasonably narrow, which could suggest that the outcome is not totally unpredictable.

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. We would highlight that Corticeira Amorim S.G.P.S' revenue growth is expected to slow, with the forecast 0.1% annualised growth rate until the end of 2025 being well below the historical 5.9% p.a. growth over the last five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 3.1% per year. Factoring in the forecast slowdown in growth, it seems obvious that Corticeira Amorim S.G.P.S is also expected to grow slower than other industry participants.

The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. The consensus price target held steady at €10.73, with the latest estimates not enough to have an impact on their price targets.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for Corticeira Amorim S.G.P.S going out to 2027, and you can see them free on our platform here..

You should always think about risks though. Case in point, we've spotted 1 warning sign for Corticeira Amorim S.G.P.S you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.